Clinical Report: Survival After Preemptive Versus Nonpreemptive Kidney Transplantation

Overview

This US registry-based target trial emulation evaluated preemptive versus nonpreemptive kidney transplantation using methods intended to address selection and lead-time bias. The supplied article context describes the study design but does not provide its outcome estimates; related web context reports that bias-adjusted mortality was similar, while preemptive transplantation was associated with lower odds of delayed graft function and reduced death-censored graft failure.

Background

Preemptive kidney transplantation is performed before dialysis and is widely advocated, particularly for candidates with living donors. Guidelines support early transplant evaluation and planning for possible preemptive transplantation, and some health systems track preemptive transplant activity. However, much of the comparative evidence is observational and may be affected by selection bias, lead-time bias, and residual confounding. These limitations complicate interpretation of reported survival and graft-outcome differences.

Data Highlights

Key Findings

• The study used the first documented eGFR ≤20 mL/min/1.73 m² as time-zero, when both preemptive and nonpreemptive strategies remained possible.
• To address bias, the investigators used left-truncated Cox models and inverse probability of treatment weighting; the analysis was framed as a target trial emulation using US registry data.
• The supplied article context does not report the current study’s numerical outcome estimates, so its specific mortality and graft-outcome findings cannot be stated from that text.
• Web research context describes a related SRTR target trial emulation of 32,770 adult first kidney-alone recipients: the apparent mortality advantage disappeared after bias adjustment (HR approximately 1.02).
• That related analysis associated preemptive transplantation with lower odds of delayed graft function and reduced death-censored graft failure.
• Earlier evidence remains uncertain: the 2023 meta-analysis reported lower mortality with living-donor preemptive transplantation before adjustment, but adjusted analyses eliminated the associations.

Clinical Implications

The supplied material supports interpreting comparisons of preemptive and nonpreemptive transplantation in light of selection, lead-time, and residual confounding. Guidelines cited in the context support early referral and planning for possible preemptive transplantation, while the available study excerpt does not provide enough outcome detail to quantify the current study’s clinical effects.

Conclusion

Preemptive transplantation is supported by guideline and policy signals, but observational comparisons of survival are sensitive to analytic methods. The current article excerpt describes a bias-adjusted target trial emulation but omits its results, limiting conclusions about its specific outcome estimates.

Related Resources & Content

1. KDIGO, KDIGO, 2020 -- Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation
2. Meier-Kriesche et al., New England Journal of Medicine, 2001 -- Effect of the Use or Nonuse of Long-Term Dialysis on the Subsequent Survival of Renal Transplants from Living Donors
3. OPTN/SRTR, OPTN/SRTR Annual Data Report, 2024 -- OPTN/SRTR 2024 Annual Data Report: Kidney
4. Pharmacoepidemiology and Drug Safety — A Nationwide Database-Driven Pharmaco-Epidemiological Study on Kidney Transplantation
5. Concurrent Ipsilateral Nephrectomy During Kidney Transplantation for Autosomal Dominant Polycystic Kidney Disease: A Matched Pair Study of 193 Cases
6. the pathologist — Catching Cast-Off Kidneys
7. Frontiers in Immunology — The potential role of antimetabolite in preventing allosensitization before kidney retransplantation
8. KDIGO 2020 Transplant Candidate Guideline
9. OPTN/SRTR 2024 Annual Data Report: Kidney
10. Effect of the Use or Nonuse of Long-Term Dialysis on the Subsequent Survival of Renal Transplants from Living Donors